MARAL PHARMA
Board
1 director, since incorporationDirector (not named in the articles)
since 29-03-2023
term without a fixed end
listed in the 2025 annual accounts, filed on 23-07-2026
- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- Each director alonedeed of 31-03-2023
Mandates through the years
1 name, the dashed line is todayDirector (not named in the articles)
Board
Mandates as a list
-
- Director (not named in the articles), from 29-03-2023 to date
Control
Founder
This company
MARAL PHARMA
Equity €164,874
Profit €66,284 in 2025
Capital
- Contribution
- €10,000
- Shares
- 100
- Contribution per share
- €100
- Equity per share
- €1,649 in 2025
- Source
- deed of 31-03-2023
Articles of association
deed of 31-03-2023 (in French)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Board ruleThese rules set how the board is made up, meets and takes decisions.
- At least 1 director
- Kind of sharesThe articles set which classes of shares exist and what rights each class carries.
- 100 shares
- Transfer restrictionThis rule says whether shareholders may sell their shares freely or need approval first.
- “Héritiers et légataires ne devenant pas de plein droit actionnaires tenus de solliciter agrément mêmes formalités, par écrit,par pli…”
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- Last Friday of June at 18:00
- Statutory auditorA statutory auditor is a registered auditor who checks the annual accounts. Small companies need not have one.
- No statutory auditor
Shareholders
At incorporation
deed of 31-03-2023 ↗
- 100 shares (100%) · €10,000 in cash